Brett Sandercock, Chief Financial Officer at RESMED INC (RMD), sold 1,000 shares at $254.30 ($254K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Scheduled sale ($254k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RMD | SELL | 2026-01-05 | $242K | — | Filing → |
| RMD | SELL | 2025-12-02 | $244K | — | Filing → |
| RMD | SELL | 2025-11-04 | $743K | — | Filing → |